Please login to the form below

Not currently logged in
Email:
Password:

Cellectis’ Mathieu Simon will serve as interim chief medical officer

He will take over the responsibilities of Loan Hoang-Sayag

Mathieu SimonCellectis has appointed Mathieu Simon to as interim chief medical officer, taking over the role from Loan Hoan-Sayag, who has left the French biopharmaceutical group to “pursue other opportunities”.

As current executive vice president and chief operating officer, Simon was previously chief executive officer of former subsidiary Cellectis Therapeutics has been “instrumental in the strategic and operational management of all therapeutic activities”.

His other roles include senior vice president, global pharma operations for Pierre Fabre and has held numerous senior roles with Wyeth Pharmaceuticals, before it was acquired by Pfizer for $68bn back in 2009.

16th October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...